[Clinical analysis of liver dysfunction induced by SHR-1210 alone or combined with apatinib and chemotherapy in patients with advanced esophageal squamous cell carcinoma].

MLA

Qi, L., et al. “[Clinical Analysis of Liver Dysfunction Induced by SHR-1210 Alone or Combined with Apatinib and Chemotherapy in Patients with Advanced Esophageal Squamous Cell Carcinoma].” Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology], vol. 45, no. 3, Mar. 2023, pp. 259–64. EBSCOhost, https://doi.org/10.3760/cma.j.cn112152-20200927-00858.

APA

Qi, L., Zhang, B., Liu, Y., Mu, L., Li, Q., Wang, X., Xu, J. P., Wang, X. Y., & Huang, J. (2023). [Clinical analysis of liver dysfunction induced by SHR-1210 alone or combined with apatinib and chemotherapy in patients with advanced esophageal squamous cell carcinoma]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology], 45(3), 259–264. https://doi.org/10.3760/cma.j.cn112152-20200927-00858

Chicago

Qi, L, B Zhang, Y Liu, L Mu, Q Li, X Wang, J P Xu, X Y Wang, and J Huang. 2023. “[Clinical Analysis of Liver Dysfunction Induced by SHR-1210 Alone or Combined with Apatinib and Chemotherapy in Patients with Advanced Esophageal Squamous Cell Carcinoma].” Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology] 45 (3): 259–64. doi:10.3760/cma.j.cn112152-20200927-00858.